<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNS</journal-id><journal-title-group><journal-title>Open Journal of Natural Science</journal-title></journal-title-group><issn pub-type="epub">2330-1724</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/OJNS.2021.91018</article-id><article-id pub-id-type="publisher-id">OJNS-40064</article-id><article-categories><subj-group subj-group-type="heading"><subject>OJNS20210100000_46096622.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>数学与物理</subject><subject> 地球与环境</subject><subject> 信息通讯</subject><subject> 生命科学</subject><subject> 化学与材料</subject></subj-group></article-categories><title-group><article-title>
 
 
  Irisin的生理效应及其研究进展
  Physiological Effects of Irisin and its Research Progress
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>孙</surname><given-names>卓</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>范</surname><given-names>锦博</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>梁</surname><given-names>向艳</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>赵</surname><given-names>妍妍</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>小春</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>丽君</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>孙</surname><given-names>霞</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>赵</surname><given-names>玉峰</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>西安医学院基础医学部病原微生物教研室，陕西 西安</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>西安医学院基础医学部基础医学研究所，陕西 西安</addr-line></aff><pub-date pub-type="epub"><day>31</day><month>12</month><year>2020</year></pub-date><volume>09</volume><issue>01</issue><fpage>147</fpage><lpage>153</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Irisin (鸢尾素)从最初被发现在脂肪细胞棕化过程中的作用后就一直被研究者们广泛关注。它在多种组织中均有表达，在运动后及二型糖尿病，孕期糖尿病患者中表达量发生变化。由于Irisin可以改善胰岛素抵抗，促进脂肪细胞棕化，故其在糖尿病及肥胖症治疗中具有应用潜力。Irisin在神经系统发育中具有重要作用，其含量与认知水平密切相关。本文就Irisin的发现及生理效应的研究展开综述。
   Irisin has inspired great interests from scientists since it was discovered to be important for white fat browning. It is expressed in many different tissues and Irisin level has been shown to change after exercise and in Type 2 diabetes patients and gestational diabetes patients. Since Irisin improves insulin resistance and promotes fat browning, it has great potential in diabetes and obesity treatment. Irisin plays important role in nervous system development, and its level is closely related to cognitive level. This review summarizes the physiological effects of Irisin and its research progress.
 
</p></abstract><kwd-group><kwd>Irisin，脂肪代谢，白色脂肪组织，棕色脂肪组织，二型糖尿病，FNDC5, Irisin</kwd><kwd> Fat Metabolism</kwd><kwd> White Adipose Tissue</kwd><kwd> Brown Adipose Tissue</kwd><kwd> Type 2 Diabetes</kwd><kwd> FNDC5</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>Irisin (鸢尾素)从最初被发现在脂肪细胞棕化过程中的作用后就一直被研究者们广泛关注。它在多种组织中均有表达，在运动后及二型糖尿病，孕期糖尿病患者中表达量发生变化。由于Irisin可以改善胰岛素抵抗，促进脂肪细胞棕化，故其在糖尿病及肥胖症治疗中具有应用潜力。Irisin在神经系统发育中具有重要作用，其含量与认知水平密切相关。本文就Irisin的发现及生理效应的研究展开综述。</p></sec><sec id="s2"><title>关键词</title><p>Irisin，脂肪代谢，白色脂肪组织，棕色脂肪组织，二型糖尿病，FNDC5</p></sec><sec id="s3"><title>Physiological Effects of Irisin and its Research Progress</title><p>Zhuo Sun<sup>1</sup>, Jinbo Fan<sup>2</sup>, Xiangyan Liang<sup>1</sup>, Yanyan Zhao<sup>1</sup>, Xiaochun Zhang<sup>1</sup>, Lijun Zhang<sup>1</sup>, Xia Sun<sup>1</sup>, Yufeng Zhao<sup>1*</sup></p><p><sup>1</sup>Institute of Basic Medical Sciences, School of Basic Medicine, Xi’an Medical University, Xi’an Shaanxi</p><p><sup>2</sup>Pathogen Microbiology Department, School of Basic Medicine, Xi’an Medical University, Xi’an Shaanxi</p><p><img src="//html.hanspub.org/file/18-2950702x5_hanspub.png" /></p><p>Received: Dec. 25<sup>th</sup>, 2020; accepted: Jan. 21<sup>st</sup>, 2021; published: Jan. 28<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/18-2950702x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Irisin has inspired great interests from scientists since it was discovered to be important for white fat browning. It is expressed in many different tissues and Irisin level has been shown to change after exercise and in Type 2 diabetes patients and gestational diabetes patients. Since Irisin improves insulin resistance and promotes fat browning, it has great potential in diabetes and obesity treatment. Irisin plays important role in nervous system development, and its level is closely related to cognitive level. This review summarizes the physiological effects of Irisin and its research progress.</p><p>Keywords:Irisin, Fat Metabolism, White Adipose Tissue, Brown Adipose Tissue, Type 2 Diabetes, FNDC5</p><disp-formula id="hanspub.40064-formula13"><graphic xlink:href="//html.hanspub.org/file/18-2950702x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/18-2950702x8_hanspub.png" /> <img src="//html.hanspub.org/file/18-2950702x9_hanspub.png" /></p></sec><sec id="s5"><title>1. Irisin的发现</title><p>Irisin是一种可以促进白色脂肪棕化的激素。Irisin最初是在对PGC1α转基因小鼠的研究中发现的 [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>]。骨骼肌中表达量升高的PGC1a转基因小鼠不易患糖尿病或老年性肥胖，暗示这些小鼠的能量代谢系统具有特殊的改变。研究者们发现骨骼肌中的转基因PGC1a可诱导皮下脂肪的棕化。经过分析PGC1a转基因小鼠的基因表达谱发现，Fndc5的表达量明显增加，而Fndc5处理确实可以诱导体外培养的脂肪细胞中棕色脂肪基因的表达。Fndc5含有一个信号肽，两个纤维连接蛋白结构域和一个疏水结构域构成。质谱分析发现Fndc5在112位谷氨酸处被酶切后产生一种在小鼠和人之间一致性为100%的多肽，由于这个多肽从骨骼肌到脂肪等其他组织的信使作用，依据希腊神话中的信使女神Iris而被命名为Irisin。这一命名很好的概括了Irisin在运动后肌肉向脂肪(棕化和产热)以及其他和代谢相关组织传递中的化学信使作用。在表达PGC1a的骨骼肌细胞培养液中加入Irisin抗体后，其对于脂肪细胞中棕色脂肪基因表达的促进作用显著降低，暗示Irisin在脂肪细胞棕化中的重要作用。该研究还发现，Irisin可以在高脂饮食小鼠体内高效地使白色脂肪组织发生棕化，增加能量消耗并提高葡萄糖耐受性。</p></sec><sec id="s6"><title>2. Irisin表达的组织</title><p>最初研究者们利用Western [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>] 和ELISA [<xref ref-type="bibr" rid="hanspub.40064-ref2">2</xref>] 的方法测定了血浆中Irisin的含量，并利用免疫反应确定了Irisin在心肌和骨骼肌中的表达 [<xref ref-type="bibr" rid="hanspub.40064-ref3">3</xref>]。随后越来越多的研究发现Irisin也在肝 [<xref ref-type="bibr" rid="hanspub.40064-ref4">4</xref>]，脾脏，肾脏，胰腺，皮肤，脂肪 [<xref ref-type="bibr" rid="hanspub.40064-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref6">6</xref>]，汗腺，唾液腺，睾丸 [<xref ref-type="bibr" rid="hanspub.40064-ref7">7</xref>]，附睾，脑等组织中广泛地表达。这说明Irisin在细胞生理中起着重要的作用，而Irisin在多种组织器官中的其他功能则需要更多的研究来确认。</p></sec><sec id="s7"><title>3. Irisin在脂肪代谢中的作用</title><p>脂肪组织根据其颜色，解剖学位置，以及生物学功能的不同分为：白色脂肪组织(White Adipose Tissue, WAT)和棕色脂肪组织(Brown Adipose Tissue, BAT)。白色脂肪组织呈白色，主要在皮下以单细胞或在腹腔膜以紧密组织存在，其生物学功能为储存过多的能量。白色脂肪组织中油滴单个存在于每个细胞中，线粒体含量较少。棕色脂肪组织呈棕色，啮齿类动物中，棕色脂肪库主要存在于肩胛骨和胸部纵隔处 [<xref ref-type="bibr" rid="hanspub.40064-ref8">8</xref>]，其主要生物学功能为产热。棕色脂肪中油滴以多个小泡存在，线粒体数目很多。其线粒体膜上有UCP1 (uncoupling protein 1)蛋白，可以将质子从线粒体质中泵到线粒体膜间隙 [<xref ref-type="bibr" rid="hanspub.40064-ref9">9</xref>]，此过程可产热，在新生儿调节体温过程中具有重要作用。两种脂肪细胞虽都从中胚层发育而来，但起源于不同的间叶细胞干细胞谱系。</p><p>棕色脂肪按其来源以及位置的不同分为两种：经典棕色脂肪或组成型棕色脂肪(classicalBAT, cBAT)以及募集型棕色脂肪(recruitable BAT, rBAT)。经典棕色脂肪存在于小鼠和人类婴儿肩胛区域，它的前体细胞与骨骼肌的前体细胞更加相似，是表达Myf5肌原性标记的前体细胞 [<xref ref-type="bibr" rid="hanspub.40064-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref11">11</xref>]。募集型棕色脂肪在个体经运动或如长期冷暴露等产热刺激后产生于白色脂肪库和肌肉中，也被称为米色脂肪(Beige fat, Brite, brown-in-white)。米色脂肪与白色脂肪的前体相同，是不表达Myf5的前体细胞。白色脂肪转变为募集型棕色脂肪的过程被称为棕化 [<xref ref-type="bibr" rid="hanspub.40064-ref12">12</xref>]。而Irisin可以诱导白色脂肪发生棕化 [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>]。</p><p>Irisin不仅可以由肌肉分泌，同时也可以从脂肪细胞中分泌 [<xref ref-type="bibr" rid="hanspub.40064-ref6">6</xref>]。人类白色脂肪组织中FNDC5表达量虽比肌肉中低100~200倍，但也构成了血浆中Irisin的一部分 [<xref ref-type="bibr" rid="hanspub.40064-ref13">13</xref>]。</p></sec><sec id="s8"><title>4. Irisin与运动的关系</title><p>FNDC5 mRNA在运动后的啮齿动物模型 [<xref ref-type="bibr" rid="hanspub.40064-ref14">14</xref>] 和人类 [<xref ref-type="bibr" rid="hanspub.40064-ref15">15</xref>] 中都有表达。但运动对于血浆中Irisin水平的影响具有争议。最初研究者们对于运动促进人血液中Irisin水平增高得出不同的结论，同时指出不同种类的运动(耐力运动或抗阻运动，短期运动或长期运动)对血液Irisin水平有不同的影响，主要由于使用的抗体识别的是FNDC5的跨膜结构域，而不是识别被分泌的Irisin [<xref ref-type="bibr" rid="hanspub.40064-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref16">16</xref>]。近年来，越来越多的研究者开始使用质谱测定血液中Irisin含量，从而使测定结果不受到不同抗体的影响 [<xref ref-type="bibr" rid="hanspub.40064-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref18">18</xref>]。实验证明，耐力或抗阻运动都可以提高人类血液中Irisin的含量。</p></sec><sec id="s9"><title>5. Irisin在二型糖尿病中的作用</title><p>在Bostrom等最初发现Irisin的文章中指出，由于Irisin可以提高小鼠葡萄糖耐受，并降低空腹胰岛素水平，Irisin的治疗潜力值得研究 [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>]。随后大量的研究开始探究Irisin在糖尿病中的作用。大部分研究显示二型糖尿病患者血液中Irisin含量降低 [<xref ref-type="bibr" rid="hanspub.40064-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref20">20</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref21">21</xref>]，若出现二型糖尿病的并发症，如：肾脏衰竭，心血管疾病，则Irisin含量更低 [<xref ref-type="bibr" rid="hanspub.40064-ref22">22</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref23">23</xref>]。而在一型糖尿病中，Irisin水平升高 [<xref ref-type="bibr" rid="hanspub.40064-ref24">24</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref25">25</xref>]。同时，空腹血糖与Irisin含量呈正相关 [<xref ref-type="bibr" rid="hanspub.40064-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref26">26</xref>]，并且Irisin和胰岛beta细胞功能正相关 [<xref ref-type="bibr" rid="hanspub.40064-ref27">27</xref>]。</p><p>研究者们对于Irisin在孕期糖尿病患者中的含量具有争议。不同的研究者分别发现患有孕期糖尿病的女性血液中Irisin含量高于 [<xref ref-type="bibr" rid="hanspub.40064-ref28">28</xref>]，低于 [<xref ref-type="bibr" rid="hanspub.40064-ref29">29</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref30">30</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref31">31</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref32">32</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref33">33</xref>]，或相似于健康个体 [<xref ref-type="bibr" rid="hanspub.40064-ref34">34</xref>]。但是，绝大多数研究以及一个汇总分析 [<xref ref-type="bibr" rid="hanspub.40064-ref31">31</xref>] 证明孕期糖尿病患者血浆中Irisin含量降低。</p></sec><sec id="s10"><title>6. Irisin在治疗中的作用</title><p>在糖尿病 [<xref ref-type="bibr" rid="hanspub.40064-ref35">35</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref36">36</xref>] 以及胰岛素抵抗 [<xref ref-type="bibr" rid="hanspub.40064-ref37">37</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref38">38</xref>] 小鼠模型中使用Irisin可以通过调节AMPK信号通路 [<xref ref-type="bibr" rid="hanspub.40064-ref37">37</xref>] 降低糖异生作用，促进糖原生成，改善肌肉胰岛素抵抗。Irisin还可以增强糖尿病小鼠内皮细胞功能 [<xref ref-type="bibr" rid="hanspub.40064-ref39">39</xref>]。Irisin同样可以抑制由高糖 [<xref ref-type="bibr" rid="hanspub.40064-ref40">40</xref>] 或高饱和脂肪酸饮食 [<xref ref-type="bibr" rid="hanspub.40064-ref41">41</xref>] 引起的凋亡而增强胰岛β细胞存活率。由于外源Irisin可有效地使皮下脂肪棕化，理论上还可以将其制成可注射的多肽辅助治疗肥胖，糖尿病等代谢疾病 [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>]。</p></sec><sec id="s11"><title>7. Irisin还是FNDC5?</title><p>Irisin从其被发现开始就被广泛的研究，而它的前体FNDC5却被相对较少的人关注。FNDC5在新陈代谢 [<xref ref-type="bibr" rid="hanspub.40064-ref42">42</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref43">43</xref>]，心肌细胞分化 [<xref ref-type="bibr" rid="hanspub.40064-ref44">44</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref45">45</xref>]，神经发育 [<xref ref-type="bibr" rid="hanspub.40064-ref46">46</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref47">47</xref>] 中具有重要作用。而FNDC5的基因多态性在人群中与很多疾病相关：如FNDC5单核苷酸多态性rs16835198和rs726344在1976个德国受试者中和胰岛素敏感性显著相关(p &lt; 0.0253) [<xref ref-type="bibr" rid="hanspub.40064-ref48">48</xref>]，rs16835198在一项对6822名中国汉族人的基因型筛查中显示和空腹胰岛素水平显著相关(p &lt; 0.046) [<xref ref-type="bibr" rid="hanspub.40064-ref49">49</xref>]。</p></sec><sec id="s12"><title>8. Irisin在神经系统中的作用</title><p>Irisin在神经系统的发育中具有重要作用。FNDC5基因在脑的很多区域都有表达，如：小脑浦肯野细胞 [<xref ref-type="bibr" rid="hanspub.40064-ref3">3</xref>]，下丘脑 [<xref ref-type="bibr" rid="hanspub.40064-ref50">50</xref>] 以及海马体 [<xref ref-type="bibr" rid="hanspub.40064-ref51">51</xref>]。Western以及质谱证明Irisin在脑脊液中也存在 [<xref ref-type="bibr" rid="hanspub.40064-ref28">28</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref52">52</xref>]。在原代小鼠胚胎大脑皮层神经元细胞成熟过程中，以及人类胚胎干细胞来源的神经细胞分化为神经元的过程中，FNDC5含量升高 [<xref ref-type="bibr" rid="hanspub.40064-ref46">46</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref51">51</xref>]。FNDC5过表达促进小鼠胚胎干细胞向神经细胞的分化 [<xref ref-type="bibr" rid="hanspub.40064-ref53">53</xref>]，而FNDC5 knockdown显著抑制小鼠胚胎干细胞向神经细胞的分化 [<xref ref-type="bibr" rid="hanspub.40064-ref54">54</xref>]。</p><p>Irisin介导了运动对脑健康的有益作用。运动对脑健康具有很多益处，如降低痴呆和抑郁的风险，维护认知能力。而运动对于脑神经系统的作用很可能是由肌肉分泌的激素进入血液，通过血脑屏障而引起脑中基因表达的改变。PGC1a-FNDC5-BDNF通路的发现就为此提供了有力的证据。BDNF (Brain-derived neurotrophic factor)是介导由运动引起的海马齿状回细胞增殖的重要因子 [<xref ref-type="bibr" rid="hanspub.40064-ref55">55</xref>]。运动引起肌肉中PGC1a蛋白表达量升高 [<xref ref-type="bibr" rid="hanspub.40064-ref56">56</xref>]，而PGC1a促进FNDC5表达 [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>]。使用腺病毒载体在肝脏中表达FNDC5可以提高血浆中Irisin含量，并导致海马BDNF表达量升高。后期，由研究者发现，耐力运动不仅可以提高骨骼肌中Irisin表达量，还可以提高海马中Irisin的表达量 [<xref ref-type="bibr" rid="hanspub.40064-ref51">51</xref>]。</p><p>随后几项研究探索了衰老个体 [<xref ref-type="bibr" rid="hanspub.40064-ref57">57</xref>]，年轻运动员 [<xref ref-type="bibr" rid="hanspub.40064-ref58">58</xref>] 或肥胖症患者 [<xref ref-type="bibr" rid="hanspub.40064-ref59">59</xref>] 血浆中Irisin含量和认知功能的关系。其中两项研究表明Irisin与更好的认知功能相关 [<xref ref-type="bibr" rid="hanspub.40064-ref57">57</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref58">58</xref>]，而另外的一项研究发现Irisin与认知功能负相关 [<xref ref-type="bibr" rid="hanspub.40064-ref59">59</xref>]。</p></sec><sec id="s13"><title>9. 亟待解决的问题</title><p>自从Irisin在2012年被发现，研究者们对于Irisin产生了浓厚的兴趣；使用Irisin这一关键词在PubMed上搜索即可得到超过1000篇同行评审期刊上的文章。Irisin对于很多系统都具有重要的生理作用，如：糖代谢稳定，白色脂肪棕化，神经系统发育等。但是有关Irisin的研究也存在许多尚未解决的问题。</p><p>从上综述可以发现，关于Irisin的研究有很多出入，甚至结论完全相反，其中一个重要原因就是不同研究者使用的抗体或实验方法不同。人血浆中Irisin含量就有0.01 ng/ml到2000 ng/ml范围之内的不同报道 [<xref ref-type="bibr" rid="hanspub.40064-ref60">60</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref61">61</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref62">62</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref63">63</xref>] [<xref ref-type="bibr" rid="hanspub.40064-ref64">64</xref>]，这说明将样品制备步骤标准化，以及探测Irisin含量方法的统一化至关重要。</p><p>最初发现Irisin的文章中使用的抗体是识别FNDC5疏水结构域和C末端的抗体 [<xref ref-type="bibr" rid="hanspub.40064-ref1">1</xref>]，所以其中被认为是Irisin的条带可能是全长FNDC5或其他被非特异识别的蛋白。随后，识别Irisin纤维连接蛋白III结构域的抗体进入市场被广泛使用。可见，Irisin相关研究中使用的抗体也是比较研究结果之间差别的重要因素。如果样品制备步骤，使用的抗体，检测的方法不同，那么不同研究之间很难有可比性。而这也是Irisin相关生理效应研究的一个难点。</p></sec><sec id="s14"><title>基金项目</title><p>西安医学院博士启动基金“IL1RAPL1增强子激活导致失活X染色体结构松散的机制研究”项目编号：2020DOC14，主持人：孙卓。</p><p>西安医学院博士启动基金“LINC复合体在细胞减数分裂中的组装及其机制研究”项目编号：2020DOC17，主持人：范锦博。</p></sec><sec id="s15"><title>文章引用</title><p>孙 卓,范锦博,梁向艳,赵妍妍,张小春,张丽君,孙 霞,赵玉峰. Irisin的生理效应及其研究进展Physiological Effects of Irisin and its Research Progress[J]. 自然科学, 2021, 09(01): 147-153. https://doi.org/10.12677/OJNS.2021.91018</p></sec><sec id="s16"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.40064-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bostrom, P., et al. (2012) A PGC1-Alpha-Dependent Myokine That Drives Brown-Fat-Like Development of White Fat and Thermogenesis. Nature, 481, 463-468. &lt;br&gt;https://doi.org/10.1038/nature10777</mixed-citation></ref><ref id="hanspub.40064-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Huh, J.Y., et al. (2014) Irisin in Response to Acute and Chronic Whole-Body Vibration Exercise in Humans. Metabolism, 63, 918-921. &lt;br&gt;https://doi.org/10.1016/j.metabol.2014.04.001</mixed-citation></ref><ref id="hanspub.40064-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Dun, S.L., et al. (2013) Irisin-Immunoreactivity in Neural and Non-Neural Cells of the Rodent. Neuroscience, 240, 155-162.  
&lt;br&gt;https://doi.org/10.1016/j.neuroscience.2013.02.050</mixed-citation></ref><ref id="hanspub.40064-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Aydin, S., et al. (2015) Effect of Carnosine Supplementa-tion on Apoptosis and Irisin, Total Oxidant and Antioxidants Levels in the Serum, Liver and Lung Tissues in Rats Ex-posed to Formaldehyde Inhalation. Peptides, 64, 14-23.  
&lt;br&gt;https://doi.org/10.1016/j.peptides.2014.11.008</mixed-citation></ref><ref id="hanspub.40064-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Moreno-Navarrete, J.M., et al. (2013) Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association with Obesity and Insulin Resistance. The Journal of Clinical Endocrinology and Metabolism, 98, E769-E778.  
&lt;br&gt;https://doi.org/10.1210/jc.2012-2749</mixed-citation></ref><ref id="hanspub.40064-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Roca-Rivada, A., et al. (2013) FNDC5/Irisin Is Not Only a Myokine But Also an Adipokine. PLoS ONE, 8, e60563.  
&lt;br&gt;https://doi.org/10.1371/journal.pone.0060563</mixed-citation></ref><ref id="hanspub.40064-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Aydin, S., et al. (2014) A Comprehensive Immunohistochemical Examination of the Distribution of the Fat-Burning Protein Irisin in Biological Tissues. Peptides, 61, 130-136. &lt;br&gt;https://doi.org/10.1016/j.peptides.2014.09.014</mixed-citation></ref><ref id="hanspub.40064-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Giralt, M. and Villarroya, F. (2013) White, Brown, Beige/Brite: Different Adipose Cells for Different Functions? Endocrinology, 154, 2992-3000. &lt;br&gt;https://doi.org/10.1210/en.2013-1403</mixed-citation></ref><ref id="hanspub.40064-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Jastroch, M., et al. (2010) Mitochondrial Proton and Electron Leaks. Essays in Biochemistry, 47, 53-67.  
&lt;br&gt;https://doi.org/10.1042/bse0470053</mixed-citation></ref><ref id="hanspub.40064-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Seale, P., et al. (2008) PRDM16 Controls a Brown Fat/Skeletal Muscle Switch. Nature, 454, 961-967.  
&lt;br&gt;https://doi.org/10.1038/nature07182</mixed-citation></ref><ref id="hanspub.40064-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Timmons, J.A., et al. (2007) Myogenic Gene Expression Signature Es-tablishes That Brown and White Adipocytes Originate from Distinct Cell Lineages. Proceedings of the National Academy of Sciences of the United States of America, 104, 4401-4406. &lt;br&gt;https://doi.org/10.1073/pnas.0610615104</mixed-citation></ref><ref id="hanspub.40064-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Young, P., Arch, J.R. and Ashwell, M. (1984) Brown Adipose Tissue in the Parametrial Fat Pad of the Mouse. FEBS Letters, 167, 10-14. &lt;br&gt;https://doi.org/10.1016/0014-5793(84)80822-4</mixed-citation></ref><ref id="hanspub.40064-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Perakakis, N., et al. (2017) Physiology and Role of Irisin in Glucose Homeostasis. Nature Reviews Endocrinology, 13, 324-337. &lt;br&gt;https://doi.org/10.1038/nrendo.2016.221</mixed-citation></ref><ref id="hanspub.40064-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Roberts, M.D., et al. (2013) Elevated Skeletal Muscle Irisin Precur-sor FNDC5 mRNA in Obese OLETF Rats. Metabolism, 62, 1052-1056. &lt;br&gt;https://doi.org/10.1016/j.metabol.2013.02.002</mixed-citation></ref><ref id="hanspub.40064-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Huh, J.Y., et al. (2012) FNDC5 and Irisin in Humans: I. Pre-dictors of Circulating Concentrations in Serum and Plasma and II. mRNA Expression and Circulating Concentrations in Response to Weight Loss and Exercise. Metabolism, 61, 1725-1738. &lt;br&gt;https://doi.org/10.1016/j.metabol.2012.09.002</mixed-citation></ref><ref id="hanspub.40064-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ellefsen, S., et al. (2014) Irisin and FNDC5: Effects of 12-Week Strength Training, and Relations to Muscle Phenotype and Body Mass Composition in Untrained Women. Eu-ropean Journal of Applied Physiology, 114, 1875-1888.  
&lt;br&gt;https://doi.org/10.1007/s00421-014-2922-x</mixed-citation></ref><ref id="hanspub.40064-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Daskalopoulou, S.S., et al. (2014) Plasma Irisin Levels Progres-sively Increase in Response to Increasing Exercise Workloads in Young, Healthy, Active Subjects. European Journal of Endocrinology, 171, 343-352.  
&lt;br&gt;https://doi.org/10.1530/EJE-14-0204</mixed-citation></ref><ref id="hanspub.40064-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Jedrychowski, M.P., et al. (2015) Detection and Quantitation of Circu-lating Human Irisin by Tandem Mass Spectrometry. Cell Metabolism, 22, 734-740. &lt;br&gt;https://doi.org/10.1016/j.cmet.2015.08.001</mixed-citation></ref><ref id="hanspub.40064-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J.J., et al. (2013) Lower Circulating Irisin Is Associated with Type 2 Diabetes Mellitus. Journal of Diabetic Complications, 27, 365-369. &lt;br&gt;https://doi.org/10.1016/j.jdiacomp.2013.03.002</mixed-citation></ref><ref id="hanspub.40064-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Choi, Y.K., et al. (2013) Serum Irisin Levels in New-Onset Type 2 Diabetes. Diabetes Research and Clinical Practice, 100, 96-101. &lt;br&gt;https://doi.org/10.1016/j.diabres.2013.01.007</mixed-citation></ref><ref id="hanspub.40064-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Kurdiova, T., et al. (2014) Effects of Obesity, Diabetes and Ex-ercise on Fndc5 Gene Expression and Irisin Release in Human Skeletal Muscle and Adipose Tissue: In Vivo and in Vitro Studies. The Journal of Physiology, 592, 1091-1107.  
&lt;br&gt;https://doi.org/10.1113/jphysiol.2013.264655</mixed-citation></ref><ref id="hanspub.40064-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, M., et al. (2014) The Association of New Inflammatory Markers with Type 2 Diabetes Mellitus and Macrovascular Complications: A Preliminary Study. European Review for Medical and Pharmacological Sciences, 18, 1567-1572.</mixed-citation></ref><ref id="hanspub.40064-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J.J., et al. (2014) Relationship between Circulating Irisin, Renal Function and Body Composition in Type 2 Diabetes. Journal of Diabetic Complications, 28, 208-213. &lt;br&gt;https://doi.org/10.1016/j.jdiacomp.2013.09.011</mixed-citation></ref><ref id="hanspub.40064-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Ates, I., et al. (2017) Factors Associated with Increased Irisin Levels in the Type 1 Diabetes Mellitus. Endocrine Regulations, 51, 1-7. &lt;br&gt;https://doi.org/10.1515/enr-2017-0001</mixed-citation></ref><ref id="hanspub.40064-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Espes, D., Lau, J. and Carlsson, P.O. (2015) Increased Levels of Irisin in People with Long-Standing Type 1 Diabetes. Diabetic Medicine, 32, 1172-1176. &lt;br&gt;https://doi.org/10.1111/dme.12731</mixed-citation></ref><ref id="hanspub.40064-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Huerta, A.E., et al. (2015) Circulating Irisin and Glucose Metabolism in Overweight/Obese Women: Effects of Alpha-Lipoic Acid and Eicosapentaenoic Acid. Journal of Physiology and Bio-chemistry, 71, 547-558.  
&lt;br&gt;https://doi.org/10.1007/s13105-015-0400-5</mixed-citation></ref><ref id="hanspub.40064-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Yang, M., et al. (2014) Circulating Levels of Irisin in Mid-dle-Aged First-Degree Relatives of Type 2 Diabetes Mellitus—Correlation with Pancreatic Beta-Cell Function. Dia-betology &amp; Metabolic Syndrome, 6, 133.  
&lt;br&gt;https://doi.org/10.1186/1758-5996-6-133</mixed-citation></ref><ref id="hanspub.40064-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Piya, M.K., et al. (2014) The Identification of Irisin in Human Cere-brospinal Fluid: Influence of Adiposity, Metabolic Markers, and Gestational Diabetes. American Journal of Physiolo-gy-Endocrinology and Metabolism, 306, E512-E518.  
&lt;br&gt;https://doi.org/10.1152/ajpendo.00308.2013</mixed-citation></ref><ref id="hanspub.40064-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Kuzmicki, M., et al. (2014) Serum Irisin Concentration in Women with Gestational Diabetes. Gynecological Endocrinology, 30, 636-639. &lt;br&gt;https://doi.org/10.3109/09513590.2014.920006</mixed-citation></ref><ref id="hanspub.40064-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Usluogullari, B., et al. (2017) Role of Serum Levels of Irisin and Oxidative Stress Markers in Pregnant Women with and without Gestational Diabetes. Gynecological Endocrinology, 33, 405-407.  
&lt;br&gt;https://doi.org/10.1080/09513590.2017.1284789</mixed-citation></ref><ref id="hanspub.40064-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, L., et al. (2015) Circulating Irisin Is Lower in Gesta-tional Diabetes Mellitus. Endocrine Journal, 62, 921-926.  
&lt;br&gt;https://doi.org/10.1507/endocrj.EJ15-0230</mixed-citation></ref><ref id="hanspub.40064-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Yuksel, M.A., et al. (2014) Maternal Serum and Fetal Cord Blood Irisin Levels in Gestational Diabetes Mellitus. Diabetes Research and Clinical Practice, 104, 171-175. &lt;br&gt;https://doi.org/10.1016/j.diabres.2013.12.025</mixed-citation></ref><ref id="hanspub.40064-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Ural, U.M., et al. (2016) Alteration of Maternal Serum Irisin Levels in Gestational Diabetes Mellitus. Ginekologia Polska, 87, 395-398. &lt;br&gt;https://doi.org/10.5603/GP.2016.0013</mixed-citation></ref><ref id="hanspub.40064-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Ebert, T., et al. (2014) Serum Levels of Irisin in Gestational Diabetes Mellitus during Pregnancy and after Delivery. Cytokine, 65, 153-158. &lt;br&gt;https://doi.org/10.1016/j.cyto.2013.11.009</mixed-citation></ref><ref id="hanspub.40064-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Liu, T.Y., et al. (2015) Irisin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis via the PI3K/Akt Pathway in Type 2 Diabetic Mice and Hepatocytes. Clinical Science, 129, 839-850.  
&lt;br&gt;https://doi.org/10.1042/CS20150009</mixed-citation></ref><ref id="hanspub.40064-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Duan, H., et al. (2016) Anti-Diabetic Activity of Recombinant Irisin in STZ-Induced Insulin-Deficient Diabetic Mice. International Journal of Biological Macromolecules, 84, 457-463. &lt;br&gt;https://doi.org/10.1016/j.ijbiomac.2015.12.049</mixed-citation></ref><ref id="hanspub.40064-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Xin, C., et al. (2016) Irisin Improves Fatty Acid Oxidation and Glucose Utilization in Type 2 Diabetes by Regulating the AMPK Signaling Pathway. International Journal of Obesity (London), 40, 443-451.  
&lt;br&gt;https://doi.org/10.1038/ijo.2015.199</mixed-citation></ref><ref id="hanspub.40064-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Yang, Z., et al. (2015) Decreased Irisin Secretion Contributes to Muscle Insulin Resistance in High-Fat Diet Mice. International Journal of Clinical and Experimental Pathology, 8, 6490-6497.</mixed-citation></ref><ref id="hanspub.40064-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, D., et al. (2015) Irisin Improves Endothelial Function in Type 2 Diabetes through Reducing Oxi-dative/Nitrative Stresses. Journal of Molecular and Cellular Cardiology, 87, 138-147. &lt;br&gt;https://doi.org/10.1016/j.yjmcc.2015.07.015</mixed-citation></ref><ref id="hanspub.40064-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Liu, S., et al. (2017) Effects and Underlying Mechanisms of Irisin on the Proliferation and Apoptosis of Pancreatic Beta Cells. PLoS ONE, 12, e0175498. &lt;br&gt;https://doi.org/10.1371/journal.pone.0175498</mixed-citation></ref><ref id="hanspub.40064-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Natalicchio, A., et al. (2017) The Myokine Irisin Is Released in Response to Saturated Fatty Acids and Promotes Pancreatic Beta-Cell Survival and Insulin Secretion. Diabetes, 66, 2849-2856. &lt;br&gt;https://doi.org/10.2337/db17-0002</mixed-citation></ref><ref id="hanspub.40064-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Cai, C., et al. (2017) Gene Location, Expression, and Function of FNDC5 in Meishan Pigs. Scientific Reports, 7, Article No. 7886. &lt;br&gt;https://doi.org/10.1038/s41598-017-08406-y</mixed-citation></ref><ref id="hanspub.40064-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Xiong, X.Q., et al. (2015) FNDC5 Overexpression and Irisin Ameliorate Glucose/Lipid Metabolic Derangements and Enhance Lipolysis in Obesity. Biochimica et Biophysica Acta, 1852, 1867-1875.  
&lt;br&gt;https://doi.org/10.1016/j.bbadis.2015.06.017</mixed-citation></ref><ref id="hanspub.40064-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Rabiee, F., et al. (2014) Induced Expression of Fndc5 Signifi-cantly Increased Cardiomyocyte Differentiation Rate of Mouse Embryonic Stem Cells. Gene, 551, 127-137. &lt;br&gt;https://doi.org/10.1016/j.gene.2014.08.045</mixed-citation></ref><ref id="hanspub.40064-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Nazem, S., et al. (2018) Fndc5 Knockdown Induced Suppression of Mitochondrial Integrity and Significantly Decreased Cardiac Differentiation of Mouse Embryonic Stem Cells. Journal of Cellular Biochemistry, 119, 4528-4539.  
&lt;br&gt;https://doi.org/10.1002/jcb.26590</mixed-citation></ref><ref id="hanspub.40064-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Ghahrizjani, F.A., et al. (2015) Enhanced Expression of FNDC5 in Human Embryonic Stem Cell-Derived Neural Cells Along with Relevant Embryonic Neural Tissues. Gene, 557, 123-129. &lt;br&gt;https://doi.org/10.1016/j.gene.2014.12.010</mixed-citation></ref><ref id="hanspub.40064-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Tanhaei, S., et al. (2018) RNA/Protein Discordant Expression of Fndc5 in Central Nervous System Is Likely to Be Mediated through microRNAs. DNA and Cell Biology, 37, 373-380. &lt;br&gt;https://doi.org/10.1089/dna.2017.4067</mixed-citation></ref><ref id="hanspub.40064-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Staiger, H., et al. (2013) Common Genetic Variation in the Human FNDC5 Locus, Encoding the Novel Muscle-Derived “Browning” Factor Irisin, Determines Insulin Sensitivity. PLoS ONE, 8, e61903.  
&lt;br&gt;https://doi.org/10.1371/journal.pone.0061903</mixed-citation></ref><ref id="hanspub.40064-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Tang, S., et al. (2014) An Interaction between a FNDC5 Variant and Obesity Modulates Glucose Metabolism in a Chinese Han Population. PLoS ONE, 9, e109957. &lt;br&gt;https://doi.org/10.1371/journal.pone.0109957</mixed-citation></ref><ref id="hanspub.40064-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Varela-Rodriguez, B.M., et al. (2016) FNDC5 Expression and Circulating Irisin Levels Are Modified by Diet and Hormonal Conditions in Hypothalamus, Adipose Tissue and Muscle. Scientific Reports, 6, Article No. 29898.  
&lt;br&gt;https://doi.org/10.1038/srep29898</mixed-citation></ref><ref id="hanspub.40064-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Wrann, C.D., et al. (2013) Exercise Induces Hippocampal BDNF through a PGC-1alpha/FNDC5 Pathway. Cell Metabolism, 18, 649-659. &lt;br&gt;https://doi.org/10.1016/j.cmet.2013.09.008</mixed-citation></ref><ref id="hanspub.40064-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Ruan, Q., et al. (2018) Detection and Quantitation of Irisin in Hu-man Cerebrospinal Fluid by Tandem Mass Spectrometry. Peptides, 103, 60-64. &lt;br&gt;https://doi.org/10.1016/j.peptides.2018.03.013</mixed-citation></ref><ref id="hanspub.40064-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Forouzanfar, M., et al. (2015) Fndc5 Overexpression Facilitat-ed Neural Differentiation of Mouse Embryonic Stem Cells. Cell Biology International, 39, 629-637. &lt;br&gt;https://doi.org/10.1002/cbin.10427</mixed-citation></ref><ref id="hanspub.40064-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Hashemi, M.S., et al. (2013) Fndc5 Knockdown Significantly Decreased Neural Differentiation Rate of Mouse Embryonic Stem Cells. Neuroscience, 231, 296-304. &lt;br&gt;https://doi.org/10.1016/j.neuroscience.2012.11.041</mixed-citation></ref><ref id="hanspub.40064-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Vaynman, S., Ying, Z. and Gomez-Pinilla, F. (2004) Hip-pocampal BDNF Mediates the Efficacy of Exercise on Synaptic Plasticity and Cognition. European Journal of Neuro-science, 20, 2580-2590.  
&lt;br&gt;https://doi.org/10.1111/j.1460-9568.2004.03720.x</mixed-citation></ref><ref id="hanspub.40064-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Olesen, J., Kiilerich, K. and Pilegaard, H. (2010) PGC-1alpha-Mediated Adaptations in Skeletal Muscle. Pflügers Archiv, 460, 153-162. &lt;br&gt;https://doi.org/10.1007/s00424-010-0834-0</mixed-citation></ref><ref id="hanspub.40064-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Kuster, O.C., et al. (2017) Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway. Journal of Alzheimer’s Disease, 59, 1097-1111. &lt;br&gt;https://doi.org/10.3233/JAD-170447</mixed-citation></ref><ref id="hanspub.40064-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Belviranli, M., et al. (2016) The Relationship between Brain-Derived Neurotrophic Factor, Irisin and Cognitive Skills of Endurance Athletes. The Physician and Sportsmedicine, 44, 290-296.  
&lt;br&gt;https://doi.org/10.1080/00913847.2016.1196125</mixed-citation></ref><ref id="hanspub.40064-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Fagundo, A.B., et al. (2016) Modulation of Irisin and Phys-ical Activity on Executive Functions in Obesity and Morbid Obesity. Scientific Reports, 6, Article No. 30820. &lt;br&gt;https://doi.org/10.1038/srep30820</mixed-citation></ref><ref id="hanspub.40064-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Crujeiras, A.B., Pardo, M. and Casanueva, F.F. (2015) Irisin: “Fat” or Ar-tefact. Clinical Endocrinology, 82, 467-474.  
&lt;br&gt;https://doi.org/10.1111/cen.12627</mixed-citation></ref><ref id="hanspub.40064-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Elbelt, U., Hofmann, T. and Stengel, A. (2013) Irisin: What Promise Does It Hold? Current Opinion in Clinical Nutrition &amp; Metabolic Care, 16, 541-547. &lt;br&gt;https://doi.org/10.1097/MCO.0b013e328363bc65</mixed-citation></ref><ref id="hanspub.40064-ref62"><label>62</label><mixed-citation publication-type="other" xlink:type="simple">Hofmann, T., Elbelt, U. and Stengel, A. (2014) Irisin as a Muscle-Derived Hormone Stimulating Thermogenesis—A Critical Update. Peptides, 54, 89-100. &lt;br&gt;https://doi.org/10.1016/j.peptides.2014.01.016</mixed-citation></ref><ref id="hanspub.40064-ref63"><label>63</label><mixed-citation publication-type="other" xlink:type="simple">Polyzos, S.A. and Mantzoros, C.S. (2015) An Update on the Validity of Irisin Assays and the Link between Irisin and Hepatic Metabolism. Metabolism, 64, 937-942. &lt;br&gt;https://doi.org/10.1016/j.metabol.2015.06.005</mixed-citation></ref><ref id="hanspub.40064-ref64"><label>64</label><mixed-citation publication-type="other" xlink:type="simple">Polyzos, S.A., Mathew, H. and Mantzoros, C.S. (2015) Irisin: A True, Circulating Hormone. Metabolism, 64, 1611-1618.  
&lt;br&gt;https://doi.org/10.1016/j.metabol.2015.09.001</mixed-citation></ref></ref-list></back></article>